HCPCS Code J7313

Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
Code effective Oct 01, 2019

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J7313 is a valid 2026 HCPCS code meaning Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg or (Inj., iluvien, 0.01 mg) for short. HCPCS J7313 has been effective since 10/01/2019 and applies to Medical care.


HCPCS Code Details - J7313

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7313
Description

Long description:
Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg

Short description:
Inj., iluvien, 0.01 mg

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
ASC payment group code Effective Jan 01, 2016 - This procedure is approved to be performed in an ambulatory surgical center.
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Oct 01, 2019
Date added Added Jan 01, 2016

See also

  • HCPCS J7312 · Injection, dexamethasone, intravitreal implant, 0.1 mg

  • HCPCS J7311 · Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg

  • HCPCS J7314 · Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.